首页> 外文期刊>The journal of sexual medicine >Male gender identity in an XX individual with congenital adrenal hyperplasia.
【24h】

Male gender identity in an XX individual with congenital adrenal hyperplasia.

机译:患有先天性肾上腺增生的XX个人中的男性性别认同。

获取原文
获取原文并翻译 | 示例
           

摘要

Based on their single case report, Jorge et al. advocated a reexamination of current standards of care for individuals with congential adrenal hyperplasia (CAH) [1]. However, such reexamination has taken place at the international consensus conference on intersex management in 2005 [2], which reviewed the available data and drew the conclusion that the available evidence supports female sex assignment of 46,XX CAH newborns. Gender dysphoria and/or patient-initiated gender change occur in both female- and male-raised 46,XX individuals with CAH at comparable rates of 5% and 12%, respectively [3], i.e., do not indicate a "common" occurrence. Thus, the burden of proof cannot be shifted by a single case report. In addition, this case report has numerous complicating features that call into question the authors' central contentions. Specifically, the child was not managed according to best practices even under the optimal-gender policy, leading to later complications.
机译:根据他们的单例报告,Jorge等人。提倡重新检查目前对患有肾上腺皮质增生(CAH)的个人的护理标准[1]。但是,在2005年有关两性管理的国际共识会议上进行了这种重新检查[2],该会议审查了现有数据并得出结论,即现有证据支持46,XX CAH新生儿的女性性别分配。性别焦虑症和/或患者引发的性别变化在女性和男性中出现的46,XX个人中,发生CAH的比例分别为5%和12%[3],即,并不表示“常见”的发生。因此,举证责任不能由单个案件报告转移。此外,该案例报告具有许多复杂的功能,这使作者的中心论点受到质疑。具体而言,即使按照最佳性别政策,也没有按照最佳做法对孩子进行管理,从而导致以后的并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号